BioSpace News Archive

FUJIFILM Diosynth Biotechnologies(Fujifilm), has announced the extension of its gene therapy and viral vaccine Fill/Finish.

Cognition Therapeutics Inc.,today announced the receipt of two multi-year grants totaling $6.6 million.

ProterixBio, Inc. today announced that results from three clinical studies of subjects with chronic obstructive pulmonary disease (COPD).

Esperion, the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), today announced positive top-line results from the third of five pivotal Phase 3 studies (Study 3 or 1002-046) expected to be reported this year.

Vince & Associates Clinical Research, an Altasciences company, announced today their strategic alliance with Altreos Research Partners.

Swift Biosciences, today named industry veteran Nathan Wood as its new CEO.

Apogenix AG provides an update on the clinical development and approval strategy of its lead drug candidate asunercept.

Genome editing company adds drug development expert in pursuit of breakthrough medicines for pediatric patients

Published studies show insufficient bowel prep can occur in over 55% of inpatient cases and lead to average of 2 day hospital stay extension and as much as $8,000 in additional costs

IOTA Pharmaceuticals Ltd today announced the creation of a new resource, the Glioblastoma (GBM) Drug Bank, to accelerate drug discovery research in brain cancer, especially glioblastoma.